Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The Evolving Landscape of PD-1/PD-L1 Pathway in Head and Neck Cancer
Xinwei Qiao, Jian Jiang, Xin Pang, et al.
Frontiers in Immunology (2020) Vol. 11
Open Access | Times Cited: 84

Showing 1-25 of 84 citing articles:

Tumor microenvironment and immunotherapy of oral cancer
Chang Liu, Min Wang, Haiyang Zhang, et al.
European journal of medical research (2022) Vol. 27, Iss. 1
Open Access | Times Cited: 77
Head and Neck Squamous Cell Carcinoma: Risk Factors, Molecular Alterations, Immunology and Peptide Vaccines
Zhe Sun, Xiaodong Sun, Zhanwei Chen, et al.
International Journal of Peptide Research and Therapeutics (2021) Vol. 28, Iss. 1
Open Access | Times Cited: 63
Novel Systemic Treatment Modalities Including Immunotherapy and Molecular Targeted Therapy for Recurrent and Metastatic Head and Neck Squamous Cell Carcinoma
Soma Ghosh, Pooja A. Shah, Faye M. Johnson
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 14, pp. 7889-7889
Open Access | Times Cited: 41
The Use of Immune Regulation in Treating Head and Neck Squamous Cell Carcinoma (HNSCC)
Che-Wei Wang, Pulak Kumar Biswas, Atikul Islam, et al.
Cells (2024) Vol. 13, Iss. 5, pp. 413-413
Open Access | Times Cited: 13
Current and Emerging Diagnostic, Prognostic, and Predictive Biomarkers in Head and Neck Cancer
Hänel W. Eberly, Bao Y. Sciscent, F. Jeffrey Lorenz, et al.
Biomedicines (2024) Vol. 12, Iss. 2, pp. 415-415
Open Access | Times Cited: 10
Therapeutic targeting of thioredoxin reductase 1 causes ferroptosis while potentiating anti-PD-1 efficacy in head and neck cancer
Ming‐Shou Hsieh, Hang Ling, Syahru Agung Setiawan, et al.
Chemico-Biological Interactions (2024) Vol. 395, pp. 111004-111004
Closed Access | Times Cited: 8
A review on the advances and challenges of immunotherapy for head and neck cancer
Gang Cheng, Hui Dong, Chen Yang, et al.
Cancer Cell International (2021) Vol. 21, Iss. 1
Open Access | Times Cited: 44
Adenovirus Encoding Tumor Necrosis Factor Alpha and Interleukin 2 Induces a Tertiary Lymphoid Structure Signature in Immune Checkpoint Inhibitor Refractory Head and Neck Cancer
James H.A. Clubb, Tatiana V. Kudling, Camilla Heiniö, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 33
The development of small-molecule inhibitors targeting HPK1
Lixin Zhou, Tianyu Wang, Kuojun Zhang, et al.
European Journal of Medicinal Chemistry (2022) Vol. 244, pp. 114819-114819
Closed Access | Times Cited: 33
The Role of Different Immunocompetent Cell Populations in the Pathogenesis of Head and Neck Cancer—Regulatory Mechanisms of Pro- and Anti-Cancer Activity and Their Impact on Immunotherapy
Katarzyna Starska
Cancers (2023) Vol. 15, Iss. 6, pp. 1642-1642
Open Access | Times Cited: 22
PI3K/AKT/mTOR Signaling Pathway in HPV-Driven Head and Neck Carcinogenesis: Therapeutic Implications
Francisco Aguayo, Francisco Perez-Dominguez, Julio Osorio, et al.
Biology (2023) Vol. 12, Iss. 5, pp. 672-672
Open Access | Times Cited: 22
AdvanTIG-105: a phase I dose escalation study of the anti-TIGIT monoclonal antibody ociperlimab in combination with tislelizumab in patients with advanced solid tumors
Sophia Frentzas, Steven Kao, Rang Gao, et al.
Journal for ImmunoTherapy of Cancer (2023) Vol. 11, Iss. 10, pp. e005829-e005829
Open Access | Times Cited: 22
The dynamic role of immune checkpoint molecules in diagnosis, prognosis, and treatment of head and neck cancers
S Mestiri, Dina Moustafa Abo El-Ella, Queenie Fernandes, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 171, pp. 116095-116095
Open Access | Times Cited: 8
A systematic review of antibody-drug conjugates and bispecific antibodies in head and neck squamous cell carcinoma and nasopharyngeal carcinoma: Charting the course of future therapies
Pablo Jiménez-Labaig, Antonio Rullan, Alberto Hernando‐Calvo, et al.
Cancer Treatment Reviews (2024) Vol. 128, pp. 102772-102772
Closed Access | Times Cited: 7
The Stromal and Immune Landscape of Nasopharyngeal Carcinoma and Its Implications for Precision Medicine Targeting the Tumor Microenvironment
Lanqi Gong, Dora Lai‐Wan Kwong, Wei Dai, et al.
Frontiers in Oncology (2021) Vol. 11
Open Access | Times Cited: 28
Gold-siRNA supraclusters enhance the anti-tumor immune response of stereotactic ablative radiotherapy at primary and metastatic tumors
Yuyan Jiang, Hongbin Cao, Huaping Deng, et al.
Nature Biotechnology (2024)
Closed Access | Times Cited: 4
NKAP: a new m6A RNA binding protein predicts prognosis and immunotherapy response in head and neck squamous cell carcinoma
Paramasivam Arumugam, Jeevitha Manicka Vasagam, Vijayashree Priyadharsini Jayaseelan
Journal of Stomatology Oral and Maxillofacial Surgery (2025), pp. 102265-102265
Closed Access
Efficacy of anti-LAG3 and anti-PD-1 combination checkpoint inhibitor therapy against head and neck squamous cell carcinoma in a genetically engineered mouse model
Felipe Lamenza, Peyton Roth, Puja Upadhaya, et al.
OncoImmunology (2025) Vol. 14, Iss. 1
Open Access
Oral cancer: Current status of preclinical research
Kirti Mathur, Vandit Shah, Jigna Shah
Elsevier eBooks (2025), pp. 349-367
Closed Access
Advancing cancer therapy: Mechanisms, efficacy, and limitations of calcium electroporation
Anna Szewczyk, Dagmara Baczyńska, Anna Choromańska, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2025), pp. 189319-189319
Closed Access
The Use of Radiology Imaging in Monitoring Treatment Response to PD-1/PD-L1 Inhibitors in Head and Neck Squamous Cell Carcinomas
Soha Mohammadi, Shaghayegh Khanmohammadi, Nima Taghizadeh Mortezaei, et al.
Interdisciplinary cancer research (2025)
Closed Access
Prognostic significance of tumor-infiltrating lymphocytes and macrophages in nasopharyngeal carcinoma: a systematic review and meta-analysis
Weixing Liu, Gui Chen, Chunyi Zhang, et al.
European Archives of Oto-Rhino-Laryngology (2021) Vol. 279, Iss. 1, pp. 25-35
Closed Access | Times Cited: 25
Pembrolizumab in the first-line treatment of advanced head and neck cancer
Luana Guimarães de Sousa, Renata Ferrarotto
Expert Review of Anticancer Therapy (2021) Vol. 21, Iss. 12, pp. 1321-1331
Closed Access | Times Cited: 25
Electroporation in Head-and-Neck Cancer: An Innovative Approach with Immunotherapy and Nanotechnology Combination
Silvia Pisani, Giulia Bertino, Adriele Prina‐Mello, et al.
Cancers (2022) Vol. 14, Iss. 21, pp. 5363-5363
Open Access | Times Cited: 17
Immunotherapy in Head and Neck Cancer When, How, and Why?
D. Pereira, Diana Martins, Fernando Mendes
Biomedicines (2022) Vol. 10, Iss. 9, pp. 2151-2151
Open Access | Times Cited: 14
Page 1 - Next Page

Scroll to top